Your browser doesn't support javascript.
loading
Quality Appraisal in Systematic Literature Reviews of Studies Eliciting Health State Utility Values: Conceptual Considerations.
Muchadeyi, Muchandifunga Trust; Hernandez-Villafuerte, Karla; Di Tanna, Gian Luca; Eckford, Rachel D; Feng, Yan; Meregaglia, Michela; Peasgood, Tessa; Petrou, Stavros; Ubels, Jasper; Schlander, Michael.
Afiliação
  • Muchadeyi MT; Division of Health Economics, German Cancer Research Centre (DKFZ) Foundation under Public Law, Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.
  • Hernandez-Villafuerte K; Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
  • Di Tanna GL; Division of Health Economics, German Cancer Research Centre (DKFZ) Foundation under Public Law, Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.
  • Eckford RD; Department of Business Economics, Health and Social Care (DEASS), University of Applied Sciences and Arts of Southern Switzerland, Manno, Lugano, Switzerland.
  • Feng Y; The George Institute for Global Health, University of New South Wales (UNSW Sydney), Sydney, NSW, Australia.
  • Meregaglia M; Division of Health Economics, German Cancer Research Centre (DKFZ) Foundation under Public Law, Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.
  • Peasgood T; Wolfson Institute of Population Health, Queen Mary University of London, London, UK.
  • Petrou S; Centre for Research on Health and Social Care Management (CERGAS), SDA Bocconi School of Management, Milan, Italy.
  • Ubels J; Melbourne School of Population and Global Health, University of Melbourne, Melbourne, VIC, Australia.
  • Schlander M; Sheffield Centre for Health and Related Research, University of Sheffield, Sheffield, UK.
Pharmacoeconomics ; 42(7): 767-782, 2024 Jul.
Article em En | MEDLINE | ID: mdl-38551803
ABSTRACT

BACKGROUND:

The increasing number of studies that generate health state utility values (HSUVs) and the impact of HSUVs on cost-utility analyses make a robust tailored quality appraisal (QA) tool for systematic reviews of these studies necessary.

OBJECTIVE:

This study aimed to address conceptual issues regarding QA in systematic reviews of studies eliciting HSUVs by establishing a consensus on the definitions, dimensions and scope of a QA tool specific to this context.

METHODS:

A modified Delphi method was used in this study. An international multidisciplinary panel of seven experts was purposively assembled. The experts engaged in two anonymous online survey rounds. After each round, the experts received structured and controlled feedback on the previous phase. Controlled feedback allowed the experts to re-evaluate and adjust their positions based on collective insights. Following these surveys, a virtual face-to-face meeting was held to resolve outstanding issues. Consensus was defined a priori at all stages of the modified Delphi process.

RESULTS:

The response rates to the first-round and second-round questionnaires and the virtual consensus meeting were 100%, 86% and 71%, respectively. The entire process culminated in a consensus on the definitions of scientific quality, QA, the three QA dimensions-reporting, relevance and  methodological quality-and the scope of a QA tool specific to studies that elicit HSUVs.

CONCLUSIONS:

Achieving this consensus marks a pivotal step towards developing a QA tool specific to systematic reviews of studies eliciting HSUVs. Future research will build on this foundation, identify QA items, signalling questions and response options, and develop a QA tool specific to studies eliciting HSUVs.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Técnica Delphi / Análise Custo-Benefício Limite: Humans Idioma: En Revista: Pharmacoeconomics Assunto da revista: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Técnica Delphi / Análise Custo-Benefício Limite: Humans Idioma: En Revista: Pharmacoeconomics Assunto da revista: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Alemanha